| Autor: |
Romanowski, Eric G., Roba, Laurie A., Wiley, Lee, Araullo-Cruz, Trinita, Gordon, Y. Jerold |
| Zdroj: |
Archives of Ophthalmology; May 1996, Vol. 114 Issue: 5 p581-585, 5p |
| Abstrakt: |
OBJECTIVE: To evaluate the effects of Pred Forte (prednisolone acetate; Allergan Pharmaceutical, Irvine, Calif) on the replication of different adenoviral serotypes in vitro and in the adenovirus type 5/New Zealand rabbit ocular model. METHODS: The 50% inhibitory doses of Pred Forte and its components were determined for common ocular serotypes. The effects of continuous topical treatment with Pred Forte for 18 days were evaluated (eg, conjunctivitis, subepithelial immune infiltrates, and serial ocular viral titers) in the adenovirus 5/New Zealand rabbit ocular model. RESULTS: Pred Forte and prednisolone acetate inhibited adenoviruses 1, 5, 8, and 19 in vitro. In vivo, 1% Pred Forte significantly reduced conjunctivitis (P=.04) and subepithelial infiltrates (P=.02), but enhanced viral replication (P=.01) on days 9 to 21 and increased the duration of viral shedding (P<.001). CONCLUSIONS: Despite demonstrated anti-inflammatory and anti-immune effects, prolonged treatment of acute adenoviral infections with topical Pred Forte is not recommended because of the enhanced risks of viral transmission and community epidemics. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
